Egyptian Journal of Bronchology

Scope & Guideline

Fostering collaboration in the fight against bronchial diseases.

Introduction

Immerse yourself in the scholarly insights of Egyptian Journal of Bronchology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1687-8426
PublisherSPRINGER
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationEGYPT J BRONCHOL / Egypt. J. Bronchol.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The Egyptian Journal of Bronchology focuses on advancing knowledge in the field of respiratory medicine, with a particular emphasis on clinical research, innovative diagnostic techniques, and evidence-based treatment modalities. It serves as a platform for disseminating research that addresses significant challenges in respiratory health, particularly in the context of the Egyptian healthcare landscape.
  1. Respiratory Diseases and Conditions:
    The journal covers a wide range of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pulmonary hypertension, pneumonia, and tuberculosis, reflecting the prevalence and importance of these conditions in Egypt and beyond.
  2. Innovative Diagnostic Techniques:
    There is a strong focus on the development and evaluation of advanced diagnostic methods, such as endobronchial ultrasound, transthoracic echocardiography, and imaging modalities, aimed at improving the accuracy of disease detection and management.
  3. COVID-19 Research:
    A significant portion of the journal's output is dedicated to research on COVID-19, including its clinical features, outcomes, and the impact of various treatment strategies, highlighting the journal's responsiveness to emerging public health challenges.
  4. Clinical Management and Therapeutics:
    The journal emphasizes studies that explore therapeutic interventions and management strategies for respiratory diseases, including the efficacy of medications and non-invasive ventilation techniques, providing insights into best practices.
  5. Public Health and Epidemiology:
    Research related to public health issues, epidemiological studies, and the impact of environmental factors on respiratory health is a core area, addressing broader determinants of health in the population.
The Egyptian Journal of Bronchology has identified several trending and emerging themes in its recent publications, reflecting the evolving landscape of respiratory research and clinical practice. These themes highlight new challenges and advancements in the field.
  1. Long COVID and Post-Acute Sequelae:
    Research on long COVID and its sequelae has surged, with multiple studies exploring persistent respiratory symptoms and their management, reflecting a growing recognition of this condition's impact on public health.
  2. Telemedicine and Remote Monitoring:
    The rise of telemedicine as a response to the COVID-19 pandemic has led to increased research on remote patient monitoring and virtual care strategies, indicating a shift towards innovative healthcare delivery models.
  3. Inflammatory Markers and Biomarkers:
    There is a notable trend towards investigating inflammatory markers and biomarkers as predictors of disease severity and outcomes in respiratory conditions, enhancing the understanding of pathophysiology and aiding in personalized medicine.
  4. Interdisciplinary Approaches in Respiratory Care:
    Emerging studies are increasingly adopting interdisciplinary approaches that integrate pulmonology with other specialties, such as cardiology and infectious diseases, to address complex patient needs effectively.
  5. Sleep Disorders and Respiratory Health:
    Research focusing on the interplay between sleep disorders, such as obstructive sleep apnea, and respiratory health has gained traction, underscoring the importance of comprehensive management strategies for affected patients.

Declining or Waning

While the Egyptian Journal of Bronchology continues to thrive in various research areas, certain themes appear to be experiencing a decline in prominence. This waning interest may reflect shifting priorities in research focus or advancements in understanding specific conditions.
  1. Tuberculosis Studies:
    Although tuberculosis remains a critical health issue, the frequency of dedicated studies on this disease has decreased in recent publications, possibly due to a shift towards more pressing global health concerns, such as COVID-19.
  2. Pediatric Respiratory Conditions:
    Research specifically targeting pediatric respiratory issues has become less frequent, indicating a potential reduction in focus on this demographic, despite the importance of addressing childhood respiratory health.
  3. Environmental Impact Studies:
    There appears to be a waning interest in studies examining the impact of environmental factors on respiratory diseases, as recent publications have not prioritized this area as heavily as before.

Similar Journals

Zeitschrift fur Pneumologie

Pioneering Discoveries in Respiratory Medicine
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.

Turkish Thoracic Journal

Fostering collaboration in the pursuit of respiratory excellence.
Publisher: AVESISSN: Frequency: 6 issues/year

Turkish Thoracic Journal, published by AVES, is a prominent open-access platform dedicated to advancing the field of pulmonary and respiratory medicine. Since its establishment, the journal has aimed to disseminate significant research findings, clinical studies, and reviews that contribute to an improved understanding of respiratory health challenges, with a particular focus on the Turkish context and regional issues. With an E-ISSN of 2149-2530 and transitioning to open access in 2022, the journal enhances visibility and accessibility, inviting a global audience of researchers, clinicians, and students to engage with the latest scientific work. The Turkish Thoracic Journal has been indexed in major databases, although it faced a coverage discontinuation in Scopus between 2016 and 2022. Currently positioned within the 23rd percentile among its peers in the field, it invites submissions that explore innovative approaches to thoracic health, enriching the discourse in a vital area of medicine.

Respiratory Investigation

Elevating research for better respiratory care.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

Minerva Respiratory Medicine

Fostering collaboration for improved respiratory outcomes.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2784-8477Frequency: 4 issues/year

Minerva Respiratory Medicine is a prominent academic journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by EDIZIONI MINERVA MEDICA in Italy, this journal provides a vital platform for the dissemination of innovative research, clinical studies, and review articles that address the complexities of respiratory health. With an ISSN of 2784-8477 and an E-ISSN of 2724-6493, it serves as an open-access resource, allowing researchers, healthcare professionals, and students access to invaluable information without barriers. The journal is categorized in the fourth quartile of the 2023 rankings in the field of pulmonary and respiratory medicine, indicating its emerging role in the academic landscape. Despite its nascent status—converging from 2021 to 2024—Minerva Respiratory Medicine is committed to enhancing knowledge and practice in respiratory care, focusing on both innovative therapies and traditional approaches. With its aim to foster collaboration and communication among professionals in the field, this journal is an essential resource for those passionate about improving respiratory health outcomes.

Canadian Journal of Respiratory Critical Care and Sleep Medicine

Elevating standards in critical and sleep medicine.
Publisher: TAYLOR & FRANCIS INCISSN: 2474-5332Frequency: 4 issues/year

Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.

Annals of the American Thoracic Society

Transforming respiratory medicine with timely and relevant contributions.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Connecting Researchers and Practitioners in Clinical Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Tuberkuloz ve Toraks-Tuberculosis and Thorax

Championing excellence in thoracic disease scholarship.
Publisher: TURKISH ASSOC TUBERCULOSIS & THORAXISSN: 0494-1373Frequency: 4 issues/year

Tuberkuloz ve Toraks (Tuberculosis and Thorax) is a distinguished journal published by the TURKISH ASSOCIATION OF TUBERCULOSIS AND THORAX located in Turkey. Serving as a pivotal platform for researchers and practitioners in the fields of Critical Care, Intensive Care Medicine, and Pulmonary and Respiratory Medicine, this journal has been disseminating vital research since 2003 and is committed to advancing knowledge and clinical practices related to tuberculosis and thoracic diseases. Although currently not an Open Access publication, its relevance is underscored by its rankings within Scopus, including a Q3 category in Critical Care and Intensive Care Medicine and a Q4 in Pulmonary and Respiratory Medicine, reflecting its significant contributions to the academic community. With a mission to foster the exchange of innovative ideas and encourage rigorous scholarly discourse, Tuberkuloz ve Toraks plays an essential role in addressing pressing health challenges associated with respiratory ailments and remains an invaluable resource for researchers, health professionals, and students dedicated to improving outcomes in thoracic health.

LUNG

Innovating the future of pulmonary medicine with every publication.
Publisher: SPRINGERISSN: 0341-2040Frequency: 6 issues/year

LUNG is a prestigious academic journal that has been a cornerstone in the field of Pulmonary and Respiratory Medicine since its inception in 1959. Published by SPRINGER, the journal holds an impressive Q1 ranking in its category for 2023, reflecting its commitment to disseminating high-quality research and advancing clinical practices in respiratory health. With a Scopus rank of 24 out of 155 in its field, representing the top 16% of journals, LUNG continues to serve as a vital platform for researchers, clinicians, and students who are dedicated to addressing the complexities of lung diseases. Although currently not an open-access journal, LUNG offers valuable insights and significant contributions to the understanding of respiratory conditions, ensuring that its readership stays at the forefront of medical advancements. Researchers and professionals are encouraged to submit their work and engage with a thriving academic community that is passionate about improving patient outcomes in pulmonary health.

Pulmonology

Connecting theory to practice in the dynamic world of lung health.
Publisher: ELSEVIERISSN: 2531-0437Frequency: 6 issues/year

Pulmonology, an esteemed journal published by Elsevier, serves as a vital platform for advancing knowledge in the field of Pulmonary and Respiratory Medicine. Since its transition to Open Access in 2018, this journal has successfully fostered a global readership, allowing for unrestricted dissemination of cutting-edge research. With an impressive Scopus ranking of #8 out of 155 in its category and a notable 2023 Q1 status, Pulmonology consistently showcases high-quality studies and reviews that contribute to the understanding and treatment of respiratory disorders. Authors and readers alike benefit from its commitment to publish influential research that addresses contemporary challenges in lung health. By bridging the gap between theory and clinical practice, the journal paves the way for innovative practices in pulmonology, making it an indispensable resource for researchers, healthcare professionals, and students interested in this dynamic field.